These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7521439)

  • 21. [Ocular findings in hepatitis C patients treated with interferon].
    Mrugacz M; Lebensztejn D
    Klin Oczna; 2010; 112(7-9):253-6. PubMed ID: 21121130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon may cause retinopathy during hepatitis therapy.
    Shahidullah AB; Cerulli MA; Berman DH
    Am J Gastroenterol; 1995 Sep; 90(9):1543. PubMed ID: 7661198
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon associated retinopathy.
    Khan H; Hamid K; Feroze AH
    J Pak Med Assoc; 2008 Jan; 58(1):48-9. PubMed ID: 18297981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.
    Hauser P; Khosla J; Aurora H; Laurin J; Kling MA; Hill J; Gulati M; Thornton AJ; Schultz RL; Valentine AD; Meyers CA; Howell CD
    Mol Psychiatry; 2002; 7(9):942-7. PubMed ID: 12399946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotton wool spots associated with interferon beta-1 alpha therapy.
    Longmuir R; Lee AG; Rouleau J
    Semin Ophthalmol; 2007; 22(1):49-53. PubMed ID: 17366120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
    Iwabuchi S; Yoshida H; Fukui S
    Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autoimmune disorders in interferon therapy].
    Okanoue T; Itoh Y; Yasui K
    Nihon Rinsho; 1994 Jul; 52(7):1924-8. PubMed ID: 7521440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis.
    Baker ML; Hand PJ; Wong TY; Liew G; Rochtchina E; Mitchell P; Lindley RI; Hankey GJ; Wang JJ;
    Arch Neurol; 2010 Oct; 67(10):1224-30. PubMed ID: 20937950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term prognosis after interferon therapy in chronic hepatitis type C].
    Inoue O; Yano M
    Nihon Rinsho; 1994 Jul; 52(7):1828-31. PubMed ID: 7521425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
    Abe Y; Ueda T; Kato T; Kohli Y
    Nihon Rinsho; 1994 Jul; 52(7):1817-22. PubMed ID: 7521424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychoneurological symptoms during interferon therapy in patients with chronic hepatitis: prospective study on predictive use of Cornell Medical Index and electroencephalogram.
    Tanaka Y; Nagaki M; Tomita E; Murase M; Enya M; Nishigaki Y; Sugihara J; Moriwaki H
    Liver Int; 2004 Oct; 24(5):407-12. PubMed ID: 15482335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
    Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
    J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon causes ischemic ocular diseases--case studies and review of the literature].
    Stoffelns BM
    Klin Monbl Augenheilkd; 2006 May; 223(5):367-71. PubMed ID: 16705506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.
    Xue JH; Zhu HH; Wang J; Chen Z
    World J Gastroenterol; 2014 Jun; 20(23):7505-13. PubMed ID: 24966622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.
    Hayasaka S; Fujii M; Yamamoto Y; Noda S; Kurome H; Sasaki M
    Br J Ophthalmol; 1995 Feb; 79(2):150-2. PubMed ID: 7696235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.